1. Home
  2. VRME vs IMNN Comparison

VRME vs IMNN Comparison

Compare VRME & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.68

Market Cap

10.4M

Sector

Technology

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$3.84

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
IMNN
Founded
1999
1982
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
12.9M
IPO Year
N/A
1985

Fundamental Metrics

Financial Performance
Metric
VRME
IMNN
Price
$0.68
$3.84
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$1.50
$182.61
AVG Volume (30 Days)
445.9K
33.1K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$3.56
52 Week High
$5.00
$41.22

Technical Indicators

Market Signals
Indicator
VRME
IMNN
Relative Strength Index (RSI) 42.74 39.01
Support Level $0.63 $3.80
Resistance Level $0.72 $4.00
Average True Range (ATR) 0.07 0.18
MACD 0.00 0.00
Stochastic Oscillator 14.90 0.00

Price Performance

Historical Comparison
VRME
IMNN

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: